Literature DB >> 11520709

Anticoagulants for acute respiratory distress syndrome: can they work?

S Idell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11520709     DOI： 10.1164/ajrccm.164.4.2102095

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  18 in total

Review 1.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

2.  Feasibility of tissue plasminogen activator formulated for pulmonary delivery.

Authors:  John S Dunn; Rajiv Nayar; Jackie Campos; Brooks M Hybertson; Yue Zhou; Mark Cornell Manning; John E Repine; Kathleen A Stringer
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury.

Authors:  Jean-Christophe Richard; Fabienne Bregeon; Véronique Leray; Didier Le Bars; Nicolas Costes; Christian Tourvieille; Franck Lavenne; Mojgan Devouassoux-Shisheboran; Gerard Gimenez; Claude Guerin
Journal:  Intensive Care Med       Date:  2007-08-02       Impact factor: 17.440

Review 4.  Anticoagulant therapy in acute respiratory distress syndrome.

Authors:  Marta Camprubí-Rimblas; Neus Tantinyà; Josep Bringué; Raquel Guillamat-Prats; Antonio Artigas
Journal:  Ann Transl Med       Date:  2018-01

5.  Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.

Authors:  Jason D Christie; Nancy Robinson; Lorraine B Ware; Michael Plotnick; Joao De Andrade; Vibha Lama; Aaron Milstone; Jonathan Orens; Ann Weinacker; Ejigayehu Demissie; Scarlett Bellamy; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

Review 6.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

Review 7.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier.

Authors:  Khalil Bdeir; Abd Al-Roof Higazi; Irina Kulikovskaya; Melpo Christofidou-Solomidou; Sergei A Vinogradov; Timothy C Allen; Steven Idell; Rose Linzmeier; Tomas Ganz; Douglas B Cines
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

9.  Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.

Authors:  Sophia Karandashova; Galina Florova; Ali O Azghani; Andrey A Komissarov; Kathy Koenig; Torry A Tucker; Timothy C Allen; Kris Stewart; Amy Tvinnereim; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-20       Impact factor: 6.914

10.  Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity.

Authors:  Julie A Bastarache; Ling Wang; Zhengming Wang; Kurt H Albertine; Michael A Matthay; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-29       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.